Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) shares traded down 6.9% during mid-day trading on Monday . The company traded as low as $23.01 and last traded at $23.98. 23,722 shares were traded during mid-day trading, a decline of 65% from the average session volume of 67,086 shares. The stock had previously closed at $25.76.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings raised shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, February 9th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company presently has a consensus rating of “Hold”.
Get Our Latest Research Report on Anbio Biotechnology
Anbio Biotechnology Stock Performance
Anbio Biotechnology Company Profile
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.
See Also
- Five stocks we like better than Anbio Biotechnology
- Paper assets fail first when systems reset
- REVEALED: Something Big Happening Behind White House Doors
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- Gilder: Don’t Buy AI Stocks, Do This Instead
- Elon Musk already made me a “wealthy man”
Receive News & Ratings for Anbio Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anbio Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
